 | • レポートコード：B-GIR09D3987 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、エクスビボ、インビボ等、用途別セグメントは、がん疾患、血液疾患、遺伝性疾患、その他等に区分しました。遺伝子治療の世界市場概観、企業動向、企業別遺伝子治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・遺伝子治療の市場概観 ・遺伝子治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・遺伝子治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・遺伝子治療の世界市場規模 ・遺伝子治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・遺伝子治療のアメリカ市場規模推移 ・遺伝子治療のカナダ市場規模推移 ・遺伝子治療のメキシコ市場規模推移 ・遺伝子治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・遺伝子治療のドイツ市場規模推移 ・遺伝子治療のイギリス市場規模推移 ・遺伝子治療のロシア市場規模推移 ・遺伝子治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・遺伝子治療の日本市場規模推移 ・遺伝子治療の中国市場規模推移 ・遺伝子治療の韓国市場規模推移 ・遺伝子治療のインド市場規模推移 ・遺伝子治療の東南アジア市場規模推移 ・遺伝子治療の南米市場分析（ブラジル、アルゼンチン等） ・遺伝子治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・遺伝子治療の種類別分析/販売量、売上、市場シェア（エクスビボ、インビボ） ・遺伝子治療の用途別分析/市場規模（がん疾患、血液疾患、遺伝性疾患、その他） ・遺伝子治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・遺伝子治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson’s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy。
Scope of the Report:
Today, Gene Therapy is used for Cancer Diseases, Hematological Disease and Hereditary Disease. Cancer Diseases is the largest application of Gene Therapy and its market share exceed 78% in 2018.
The global Gene Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gene Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Kite Pharma
BioVex
Novartis
Spark Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ex Vivo
In Vivo
Market Segment by Applications, can be divided into
Cancer Diseases
Hematological Disease
Hereditary Disease
Others
Table of Contents
1 Gene Therapy Market Overview
1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Types
1.2.1 Global Gene Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Gene Therapy Revenue Market Share by Types in 2018
1.2.3 Ex Vivo
1.2.4 In Vivo
1.3 Global Gene Therapy Market by Application
1.3.1 Global Gene Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer Diseases
1.3.3 Hematological Disease
1.3.4 Hereditary Disease
1.3.5 Others
1.4 Global Gene Therapy Market by Regions
1.4.1 Global Gene Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gene Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Gene Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Kite Pharma
2.1.1 Business Overview
2.1.2 Gene Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Kite Pharma Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 BioVex
2.2.1 Business Overview
2.2.2 Gene Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioVex Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Gene Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Spark Therapeutics
2.4.1 Business Overview
2.4.2 Gene Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gene Therapy Market Competition, by Players
3.1 Global Gene Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Therapy Players Market Share
3.2.2 Top 10 Gene Therapy Players Market Share
3.3 Market Competition Trend
4 Global Gene Therapy Market Size by Regions
4.1 Global Gene Therapy Revenue and Market Share by Regions
4.2 North America Gene Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Gene Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gene Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Gene Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gene Therapy Revenue and Growth Rate (2014-2019)
5 North America Gene Therapy Revenue by Countries
5.1 North America Gene Therapy Revenue by Countries (2014-2019)
5.2 USA Gene Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Gene Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Gene Therapy Revenue and Growth Rate (2014-2019)
6 Europe Gene Therapy Revenue by Countries
6.1 Europe Gene Therapy Revenue by Countries (2014-2019)
6.2 Germany Gene Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Gene Therapy Revenue and Growth Rate (2014-2019)
6.4 France Gene Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Gene Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Gene Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gene Therapy Revenue by Countries
7.1 Asia-Pacific Gene Therapy Revenue by Countries (2014-2019)
7.2 China Gene Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Gene Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Gene Therapy Revenue and Growth Rate (2014-2019)
7.5 India Gene Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gene Therapy Revenue and Growth Rate (2014-2019)
8 South America Gene Therapy Revenue by Countries
8.1 South America Gene Therapy Revenue by Countries (2014-2019)
8.2 Brazil Gene Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Gene Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Gene Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gene Therapy by Countries
9.1 Middle East and Africa Gene Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gene Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Gene Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Gene Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gene Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Gene Therapy Revenue and Growth Rate (2014-2019)
10 Global Gene Therapy Market Segment by Type
10.1 Global Gene Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Gene Therapy Market Forecast by Type (2019-2024)
10.3 Ex Vivo Revenue Growth Rate (2014-2024)
10.4 In Vivo Revenue Growth Rate (2014-2024)
11 Global Gene Therapy Market Segment by Application
11.1 Global Gene Therapy Revenue Market Share by Application (2014-2019)
11.2 Gene Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Diseases Revenue Growth (2014-2019)
11.4 Hematological Disease Revenue Growth (2014-2019)
11.5 Hereditary Disease Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Gene Therapy Market Size Forecast (2019-2024)
12.1 Global Gene Therapy Market Size Forecast (2019-2024)
12.2 Global Gene Therapy Market Forecast by Regions (2019-2024)
12.3 North America Gene Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Gene Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gene Therapy Revenue Market Forecast (2019-2024)
12.6 South America Gene Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gene Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Gene Therapy Picture
Table Product Specifications of Gene Therapy
Table Global Gene Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Gene Therapy Revenue Market Share by Types in 2018
Figure Ex Vivo Picture
Figure In Vivo Picture
Table Global Gene Therapy Revenue (Million USD) by Application (2014-2024)
Figure Gene Therapy Revenue Market Share by Applications in 2018
Figure Cancer Diseases Picture
Figure Hematological Disease Picture
Figure Hereditary Disease Picture
Figure Others Picture
Table Global Market Gene Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gene Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Kite Pharma Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Gene Therapy Type and Applications
Table Kite Pharma Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table BioVex Basic Information, Manufacturing Base and Competitors
Table BioVex Gene Therapy Type and Applications
Table BioVex Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gene Therapy Type and Applications
Table Novartis Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table Spark Therapeutics Gene Therapy Type and Applications
Table Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gene Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Gene Therapy Revenue Share by Players (2014-2019)
Figure Global Gene Therapy Revenue Share by Players in 2017
Figure Global Gene Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Gene Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Gene Therapy Revenue Market Share in 2018
Figure Global Gene Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gene Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Gene Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Gene Therapy Revenue Market Share by Regions in 2018
Figure North America Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gene Therapy Revenue and Growth Rate (2014-2019)
Figure South America Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gene Therapy Revenue and Growth Rate (2014-2019)
Table North America Gene Therapy Revenue by Countries (2014-2019)
Table North America Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Gene Therapy Revenue Market Share by Countries in 2018
Figure USA Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Gene Therapy Revenue and Growth Rate (2014-2019)
Table Europe Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Gene Therapy Revenue Market Share by Countries in 2018
Figure Germany Gene Therapy Revenue and Growth Rate (2014-2019)
Figure UK Gene Therapy Revenue and Growth Rate (2014-2019)
Figure France Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Gene Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gene Therapy Revenue Market Share by Countries in 2018
Figure China Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Gene Therapy Revenue and Growth Rate (2014-2019)
Figure India Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gene Therapy Revenue and Growth Rate (2014-2019)
Table South America Gene Therapy Revenue by Countries (2014-2019)
Table South America Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Gene Therapy Revenue Market Share by Countries in 2018
Figure Brazil Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Gene Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gene Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gene Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gene Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Gene Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Gene Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Gene Therapy Revenue and Growth Rate (2014-2019)
Table Global Gene Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Gene Therapy Revenue Share by Type (2014-2019)
Figure Global Gene Therapy Revenue Share by Type (2014-2019)
Figure Global Gene Therapy Revenue Share by Type in 2019
Table Global Gene Therapy Revenue Forecast by Type (2019-2024)
Figure Global Gene Therapy Market Share Forecast by Type (2019-2024)
Figure Global Ex Vivo Revenue Growth Rate (2014-2019)
Figure Global In Vivo Revenue Growth Rate (2014-2019)
Table Global Gene Therapy Revenue by Application (2014-2019)
Table Global Gene Therapy Revenue Share by Application (2014-2019)
Figure Global Gene Therapy Revenue Share by Application (2014-2019)
Figure Global Gene Therapy Revenue Share by Application in 2019
Table Global Gene Therapy Revenue Forecast by Application (2019-2024)
Figure Global Gene Therapy Market Share Forecast by Application (2019-2024)
Figure Global Cancer Diseases Revenue Growth Rate (2014-2019)
Figure Global Hematological Disease Revenue Growth Rate (2014-2019)
Figure Global Hereditary Disease Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gene Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gene Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gene Therapy Revenue Market Forecast (2019-2024)
Figure Europe Gene Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gene Therapy Revenue Market Forecast (2019-2024)
Figure South America Gene Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gene Therapy Revenue Market Forecast (2019-2024)
世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…- 世界のレポーター遺伝子アッセイ市場予測（～2024年） In molecular biology, a reporter gene (often simply reporter) is a gene that researchers attach to a regulatory sequence of another gene of interest in bacteria, cell culture, animals or plants. Certain genes are chosen as reporters because the characteristics they confer on organisms expressing the…
- 世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…
- 世界の癌治療における新薬デリバリーシステム市場予測（～2024年） Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. …
- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…